NCT06143332

Brief Summary

Exercise training in cardiac rehabilitation (rehab) is a key part of managing a patient with heart disease. It has been shown that cardiac patients who increase their aerobic ("cardio") fitness by exercise training live longer, have better quality of life, and stay out of hospitals more than patients who do not improve their aerobic fitness. The more a patient improves their aerobic fitness the greater the benefit. But it has been shown that more than half of patients do not improve their aerobic fitness even after participating in cardiac rehab. This may be related to how hard patients are asked to train (their training "intensity"). The way intensity is chosen in current programs is commonly based on a "one-size fits all" method that may not consider that different patients have different abilities. There are more personalized methods to determine training intensity that exist, but these have never been used in cardiac rehab. One method divides intensity into three zones (zone 1 = moderate intensity; zone 2 = heavy intensity; zone 3 = very high intensity) that are based on when an individuals' biological responses to exercise change. The purpose of this study is to see if this approach gives better results in terms of changes in aerobic fitness and if training in the different zones makes a difference. Three groups of patients will be asked to train for 3 months in one of the three intensity zones. Aerobic fitness before and after exercise training will be compared to see which intensity zone results in the largest change.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
105

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
10mo left

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Nov 2024Mar 2027

First Submitted

Initial submission to the registry

November 8, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 22, 2023

Completed
12 months until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

1.7 years

First QC Date

November 8, 2023

Last Update Submit

April 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peak oxygen uptake

    Post-training peak oxygen uptake achieved during a symptom-limited incremental exercise test to task failure

    baseline (week 0) and week 14

Secondary Outcomes (3)

  • Positive responders

    week 14

  • Gas exchange threshold

    baseline (week 0) and week 14

  • Respiratory compensation point

    baseline (week 0) and week 14

Other Outcomes (6)

  • Cardiac output

    baseline (week 0) and week 14

  • Stroke volume

    baseline (week 0) and week 14

  • Arterio-venous oxygen difference

    baseline (week 0) and week 14

  • +3 more other outcomes

Study Arms (3)

Moderate-intensity continuous training

EXPERIMENTAL

\~50 min of constant-power output cycling, 3 x per week at 85% of gas exchange threshold

Other: Aerobic exercise training

Heavy-intensity continuous training

EXPERIMENTAL

30 min of constant-power output cycling, 3 x per week at 70% of the difference between gas exchange threshold and respiratory compensation point

Other: Aerobic exercise training

High (severe)-intensity interval training

EXPERIMENTAL

intervals; 4 x 4 min on - 3 min off at 115% of respiratory compensation point (work) and 50-70% gas exchange threshold (recovery)

Other: Aerobic exercise training

Interventions

Aerobic exercise training on a cycle ergometer

Heavy-intensity continuous trainingHigh (severe)-intensity interval trainingModerate-intensity continuous training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with CAD who do not have any identified left ventricular dysfunction (i.e., left ventricular ejection fraction \[LVEF\] \<50%) and who: were discharged from the hospital following admission for acute coronary syndrome (i.e., ST-elevation or non ST-elevation myocardial infarction, addressed with PCI or CABG, as documented by their attending physician; referred to St. Joseph's CRSP Program; completed a CPET at the St. Joseph's CRSP Program (as routine screening for cardiac rehabilitation) and have been cleared to exercise in a structured format (i.e., do not exhibit any contraindications to maximal exercise); without: respiratory or musculoskeletal issues that would prohibit them from cycling exercise.

You may not qualify if:

  • Those who have: diagnosed heart failure, severe aortic stenosis, congenital coronary abnormality, 2-3° atrioventricular block, major arrhythmias such as atrial fibrillation (including paroxysmal), or are scheduled to undergo PCI or CABG surgery within 2 months following hospital discharge; are using insulin for diabetes; diagnosed with respiratory disease; or musculoskeletal issues that prohibit cycling exercise; and/or are unable to provide informed consent..

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Western Ontario

London, Ontario, N6A3K7, Canada

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Daniel A Keir, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 22, 2023

Study Start

November 1, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations